Catalyst Brief

← Calendar

Readoutin 226d

Biohaven Ltd. — Taldefgrobep

Phase 2 topline data expected (monotherapy and GLP-1 combination arms).

Date
H2 2027
Type
Readout
Ticker
BHVN
Indication
Obesity

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.